McFarlane Neil F. 4
4 · ZEVRA THERAPEUTICS, INC. · Filed Feb 3, 2025
Insider Transaction Report
Form 4
McFarlane Neil F.
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-01-31−233,333→ 466,667 total→ Common Stock (233,333 underlying) - Exercise/Conversion
Common Stock
2025-01-31+233,333→ 283,333 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The first tranche of the restricted stock units vested and settled on January 31, 2025, and the remaining two tranches of the restricted stock units will vest and settle in equal annual installments thereafter, subject in each case to the Reporting person's continued service through such vesting date.